The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. ITeos Therapeutics Inc shares valued at $440,136 were sold by Detheux Michel on Jun 09 ’25. At $10.03 per share, Detheux Michel sold 43,882 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Detheux Michel sold 43,883 shares, netting a total of over 439,708 in proceeds. Following the sale of shares at $10.02 each, the insider now holds 0 shares.
Before that, Detheux Michel had sold 8,400 shares from its account. In a trade valued at $84,252, the Chief Executive Officer traded ITeos Therapeutics Inc shares for $10.03 each. Upon closing the transaction, the insider’s holdings decreased to 8,400 shares, worth approximately $1.38 million.
As published in a research note from Wells Fargo on May 28, 2025, ITeos Therapeutics Inc [ITOS] has been rated down from an Overweight to an Equal weight and the price target has been revised to $12. Analysts at Wedbush downgraded the stock from ‘”an Outperform”‘ to ‘”a Neutral”‘ outlook in a report released in late May. As of May 14, 2025, Leerink Partners has decreased its “an Outperform” rating to a “Market perform” for ITOS. Earlier on May 14, 2025, H.C. Wainwright downgraded its rating. Their new recommendation was “a Neutral” for ITOS stock which previously was a “a Buy”.
Analyzing ITOS Stock Performance
On last trading session, ITeos Therapeutics Inc [NASDAQ: ITOS] rose 0.20% to $10.12. The stock’s lowest price that day was $10.1, but it reached a high of $10.145 in the same session. During the last five days, there has been a surge of approximately 0.10%. Over the course of the year, ITeos Therapeutics Inc shares have dropped approximately -31.20%. Shares of the company reached a 52-week high of $11.35 on 05/28/25 and a 52-week low of $4.80 on 04/09/25.
Support And Resistance Levels for ITeos Therapeutics Inc (ITOS)
According to the 24-hour chart, there is a support level at 10.10, which, if violated, would cause prices to drop to 10.07. In the upper region, resistance lies at 10.15. The next price resistance is at 10.17. RSI (Relative Strength Index) is 54.35 on the 14-day chart, showing neutral technical sentiment.
Is ITeos Therapeutics Inc subject to short interest?
Stocks of ITeos Therapeutics Inc saw a sharp rise in short interest on 2025-07-31 jumping by 0.13 million shares to 2.97 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 2.83 million shares. A jump of 4.52% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.17 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.17.
Which companies own the most shares of ITeos Therapeutics Inc (ITOS)?
In terms of ITeos Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 12 in the next 12 months, up nearly 18.81% from the previous closing price of $10.1. Analysts anticipate ITeos Therapeutics Inc stock to reach 12 by 2025, with the lowest price target being 9. In spite of this, 1 analysts ranked ITeos Therapeutics Inc stock as Buy at the end of 2025.
